Abiraterone in Prostate Cancer: a new angle to an old problem

Por Stein, Mark N., Goodin, Susan, DiPaola, Robert S.
Publicado em 2012

Androgen synthesis inhibitors in the treatment of castration-resistant prostate cancer

Por Stein, Mark N, Patel, Neal, Bershadskiy, Alexander, Sokoloff, Alisa, Singer, Eric A
Publicado em 2014

Targeting tumor-associated macrophages to combat pancreatic cancer

Por Cui, Ran, Yue, Wen, Lattime, Edmund C., Stein, Mark N., Xu, Qing, Tan, Xiang-Lin
Publicado no Oncotarget (2016)

Identification of the DNA Repair Defects in a Case of Dubowitz Syndrome

Por Yue, Jingyin, Lu, Huimei, Lan, Shijie, Liu, Jingmei, Stein, Mark N., Haffty, Bruce G., Shen, Zhiyuan
Publicado em 2013

Phase I-II study of ADXS31-142 alone and in combination with pembrolizumab in patients with previously treated metastatic castration-resistant prostate cancer (mCRPC): the KEYNOTE-...

Por Haas, Naomi B, Stein, Mark N, Tutrone, Ronald, Perini, Rodolfo, Denker, Andrew, Mauro, David, Fong, Lawrence
Publicado no J Immunother Cancer (2015)

A validated HPLC assay for the determination of R-(-)-gossypol in human plasma and its application in clinical pharmacokinetic studies

Por Lin, Hongxia, Gounder, Murugesan K., Bertino, Joseph R., Kong, Ah-Ng Tony, DiPaola, Robert S., Stein, Mark N.
Publicado em 2012

Contemporary Risk Profile of Prostate Cancer in the United States

Por Shao, Yu-Hsuan, Demissie, Kitaw, Shih, Weichung, Mehta, Amit R., Stein, Mark N., Roberts, Calpurnyia B., DiPaola, Robert S., Lu-Yao, Grace L.
Publicado em 2009

Risk Profiles and Treatment Patterns among Men diagnosed with Prostate Cancer and a Prostate Specific Antigen Level Below 4.0 ng/ml

Por Shao, Yu–Hsuan, Albertsen, Peter C., Roberts, Calpurnyia B., Lin, Yong, Mehta, Amit R., Stein, Mark N., DiPaola, Robert S., Lu–Yao, Grace L.
Publicado em 2010

Phase I study of gemcitabine, docetaxel and imatinib in refractory and relapsed solid tumors

Por Saraiya, Biren, Chugh, Rashmi, Karantza, Vassiliki, Mehnert, Janice, Moss, Rebecca A., Savkina, Nelli, Stein, Mark N., Baker, Laurence H., Chenevert, Thomas, Poplin, Elizabeth A.
Publicado no Invest New Drugs (2010)

A Phase II Study of AT-101 to Overcome Bcl-2 Mediated Resistance to Androgen Deprivation Therapy in Patients with Newly Diagnosed Castration Sensitive Metastatic Prostate Cancer

Por Stein, Mark N., Hussain, Maha, Stadler, Walter M., Liu, Glenn, Tereshchenko, Irina V., Goodin, Susan, Jeyamohan, Chandrika, Kaufman, Howard L., Mehnert, Janice, DiPaola, Robert S.
Publicado no Clin Genitourin Cancer (2015)

Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: A randomized phase II trial by the Prostate Cancer Clinical Trials Co...

Por Bradley, Deborah A., Daignault, Stephanie, Ryan, Charles J., DiPaola, Robert S., Smith, David C., Small, Eric, Gross, Mitchell E., Stein, Mark N., Chen, Alice, Hussain, Maha
Publicado em 2010

Enrichment of human prostate cancer cells with tumor initiating properties in mouse and zebrafish xenografts by differential adhesion

Por Bansal, Nitu, Davis, Stephani, Tereshchenko, Irina, Budak-Alpdogan, Tulin, Zhong, Hua, Stein, Mark N., Kim, Isaac Yi, DiPaola, Robert S., Bertino, Joseph R., Sabaawy, Hatem E.
Publicado em 2013

A phase I pharmacodynamic trial of sequential sunitinib with bevacizumab in patients with renal cell carcinoma and other advanced solid malignancies

Por Bruce, Justine Yang, Kolesar, Jill M., Hammers, Hans, Stein, Mark N., Carmichael, Lakeesha, Eickhoff, Jens, Johnston, Susan A., Binger, Kimberly A., Heideman, Jennifer L., Perlman, Scott B., Jeraj, Robert, Liu, Glenn
Publicado em 2014

A National Multicenter Phase 2 Study of Prostate-specific Antigen (PSA) Pox Virus Vaccine with Sequential Androgen Ablation Therapy in Patients with PSA Progression: ECOG 9802

Por DiPaola, Robert S., Chen, Yu-Hui, Bubley, Glenn J., Stein, Mark N., Hahn, Noah M., Carducci, Michael A., Lattime, Edmund C., Gulley, James, Arlen, Philip M., Butterfield, Lisa H., Wilding, George
Publicado no Eur Urol (2014)

A phase I study of MK-5108, an oral aurora A kinase inhibitor, administered both as monotherapy and in combination with docetaxel, in patients with advanced or refractory solid tum...

Por Amin, Manik, Minton, Susan E., LoRusso, Patricia M., Krishnamurthi, Smitha S., Pickett, Cheryl A., Lunceford, Jared, Hille, Darcy, Mauro, David, Stein, Mark N., Wang-Gillam, Andrea, Trull, Lauren, Lockhart, A. Craig
Publicado no Invest New Drugs (2015)

Rationally designed treatment for solid tumors with MAPK pathway activation: a Phase I study of paclitaxel and bortezomib using an adaptive dose-finding approach

Por Mehnert, Janice M., Tan, Antoinette R., Moss, Rebecca, Poplin, Elizabeth, Stein, Mark N., Sovak, Mika, Levinson, Kelly, Lin, Hongxia, Kane, Michael, Gounder, Murugesan, Lin, Yong, Shih, Weichung Joe, White, Eileen, Rubin, Eric H., Karantza, Vassiliki
Publicado em 2011

A Randomized Phase II Trial of Short-Course Androgen Deprivation Therapy With or Without Bevacizumab for Patients With Recurrent Prostate Cancer After Definitive Local Therapy

Por McKay, Rana R., Zurita, Amado J., Werner, Lillian, Bruce, Justine Y., Carducci, Michael A., Stein, Mark N., Heath, Elisabeth I., Hussain, Arif, Tran, Hai T., Sweeney, Christopher J., Ross, Robert W., Kantoff, Philip W., Slovin, Susan F., Taplin, Mary-Ellen
Publicado no J Clin Oncol (2016)

Samarium-153-EDTMP (Quadramet(®)) with or without vaccine in metastatic castration-resistant prostate cancer: A randomized Phase 2 trial

Por Heery, Christopher R., Madan, Ravi A., Stein, Mark N., Stadler, Walter M., Di Paola, Robert S., Rauckhorst, Myrna, Steinberg, Seth M., Marté, Jennifer L., Chen, Clara C., Grenga, Italia, Donahue, Renee N., Jochems, Caroline, Dahut, William L., Schlom, Jeffrey, Gulley, James L.
Publicado no Oncotarget (2016)

Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer

Por Mehnert, Janice M., Panda, Anshuman, Zhong, Hua, Hirshfield, Kim, Damare, Sherri, Lane, Katherine, Sokol, Levi, Stein, Mark N., Rodriguez-Rodriquez, Lorna, Kaufman, Howard L., Ali, Siraj, Ross, Jeffrey S., Pavlick, Dean C., Bhanot, Gyan, White, Eileen P., DiPaola, Robert S., Lovell, Ann, Cheng, Jonathan, Ganesan, Shridar
Publicado no J Clin Invest (2016)

BMI-1 targeting interferes with patient-derived tumor-initiating cell survival and tumor growth in prostate cancer

Por Bansal, Nitu, Bartucci, Monica, Yusuff, Shamila, Davis, Stephani, Flaherty, Kathleen, Huselid, Eric, Patrizii, Michele, Jones, Daniel, Cao, Liangxian, Sydorenko, Nadiya, Moon, Young-Choon, Zhong, Hua, Medina, Daniel J., Kerrigan, John, Stein, Mark N., Kim, Isaac Y., Davis, Thomas W., DiPaola, Robert S., Bertino, Joseph R., Sabaawy, Hatem E.
Publicado no Clin Cancer Res (2016)